DPx Holdings to Present at 2015 J.P. Morgan Healthcare Conference

DPx Holdings B.V. announced today that Chief Executive Officer James C. Mullen will present an overview of the company, and its contract development and commercial manufacturing (CDMO) business Patheon, at the 33rd Annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis in San Francisco, Calif., on Tuesday, Jan. 13 at 9:30 a.m. in the Elizabethan C meeting room.  

DPx Holdings B.V. Media Relations

Tyler Gronbach

Tel: +1 (919) 226-3201

Email: tyler.gronbach@patheon.com or media@dpxholdings.com  

About DPx Holdings B.V.

DPx Holdings B.V. is parent company of the Patheon, DPx Fine Chemicals and Banner Life Sciences businesses. DPx Holdings has a footprint of more than 20 locations across North America, Europe, Latin America and Australia. Patheon is a leading provider of CDMO services to the global pharmaceutical industry for a full array of solid and sterile dosage forms, including small molecule API and biologic drug substances. Patheon, a business unit of DPx Holdings B.V., encompasses the combined commercial manufacturing capabilities and pharmaceutical product development services, as well as offers a full array of biologic services and active pharmaceutical ingredients (API) development. For more information visit www.patheon.com/DPx.